http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3c2587b8cfe62a03630fdfdc9079f67
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Adelmant |
| name | Guillaume Adelmant |
| given-name | Guillaume |
| organization-name | Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States; Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, United States 3Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts. Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Department of Cancer Biology and Blais Proteomics Center, Dana‐Farber Cancer Institute Boston Massachusetts; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, United States; Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, United States; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, United States Department of Cancer Biology and Blais Proteomics Center; Dana-Farber Cancer Institute; Boston MA USA; Department of Biological Chemistry and Molecular Pharmacology; Harvard Medical School; Boston MA USA Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Dana–Farber Cancer Institute, Department of Cell Biology, and Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA 02115; and Center for Cardiovascular Research, Department of Medicine and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110 Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115 The Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, United States Department of Cancer Biology, Dana-Farber Cancer Institute, 02215-5450, Boston, MA, USA; Blais Proteomics Center, Dana-Farber Cancer Institute, 02215-5450, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 02115, Boston, MA, USA Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215;; Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA 02215;; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215; Department of Cancer Biology and Blais Proteomics Center, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA |
Incoming Links
Total number of triples: 64.